REVLIMID® (lenalidomide) in combination with dexamethasone (dex) is indicated for the treatment of adult patients with multiple myeloma (MM). REVLIMID is indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT). REVLIMID is not indicated and is not recommended for the treatment of patients with chronic lymphocytic leukemia (CLL) outside of controlled clinical trials.

A single source for
access support.
Celgene Patient Support® provides:
- A single Specialist assigned to help patients in your geographic area
- Assistance with understanding patient insurance coverage for REVLIMID
- Information about financial assistance for REVLIMID
Financial assistance.
Depending on your patient’s insurance situation, there are programs and organizations that may help for REVLIMID.
Celgene commercial co-pay program
For eligible patients with commercial or private insurance (including healthcare exchanges),* co-pay responsibility for REVLIMID is reduced to $25 (subject to annual benefit limit).
Celgene Patient Assistance Program (PAP)
For qualified patients who are uninsured or underinsured, REVLIMID may be available at no cost.†
Independent third-party organizations
For patients who are unable to afford their medication (including patients with Medicare, Medicaid, or other government-sponsored insurance),‡ independent third-party organizations may be able to help.
*Eligibility requirements and restrictions apply. Please see full Terms and Conditions on the Celgene Patient Support® website.
†Patients must meet specified financial and insurance eligibility requirements to qualify for assistance. Please see Eligibility Requirements on the Celgene Patient Support® website.
‡Financial and medical eligibility requirements may vary by organization.
Learn More About Financial Assistance
Insurance-related assistance.
Our Specialists are available to assist with each of the following steps in the insurance approval process for REVLIMID.§
- Benefits investigation
- Prior authorization assistance‖
- Appeals assistance‖
§Celgene cannot provide insurance advice or make insurance decisions.
‖Celgene provides a facilitation service and will not provide any medical input into a prior authorization or an appeal.
Enrolling in Celgene Patient Support.
There are three simple ways to enroll in Celgene Patient Support®.
Enroll online
Enroll online at www.celgenepatientsupport.com.
Call 1-800-931-8691
Call us at 1-800-931-8691, Monday–Friday, 8 AM-8 PM ET (translation services available).
Email or fax the enrollment form
Email us at patientsupport@celgene.com or fax 1-800-822-2496.